604 related articles for article (PubMed ID: 33099131)
1. Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features.
Zhang F; Yue L; Fang X; Wang G; Li C; Sun X; Jia X; Yang J; Song J; Zhang Y; Guo C; Ma G; Sang M; Chen F; Wang P
Parkinsonism Relat Disord; 2020 Dec; 81():84-88. PubMed ID: 33099131
[TBL] [Abstract][Full Text] [Related]
2. Dysbiosis of gut microbiota in a selected population of Parkinson's patients.
Pietrucci D; Cerroni R; Unida V; Farcomeni A; Pierantozzi M; Mercuri NB; Biocca S; Stefani A; Desideri A
Parkinsonism Relat Disord; 2019 Aug; 65():124-130. PubMed ID: 31174953
[TBL] [Abstract][Full Text] [Related]
3. Gut metagenomics-derived genes as potential biomarkers of Parkinson's disease.
Qian Y; Yang X; Xu S; Huang P; Li B; Du J; He Y; Su B; Xu LM; Wang L; Huang R; Chen S; Xiao Q
Brain; 2020 Aug; 143(8):2474-2489. PubMed ID: 32844199
[TBL] [Abstract][Full Text] [Related]
4. Alteration of the fecal microbiota in Chinese patients with Parkinson's disease.
Qian Y; Yang X; Xu S; Wu C; Song Y; Qin N; Chen SD; Xiao Q
Brain Behav Immun; 2018 May; 70():194-202. PubMed ID: 29501802
[TBL] [Abstract][Full Text] [Related]
5. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.
Hill-Burns EM; Debelius JW; Morton JT; Wissemann WT; Lewis MR; Wallen ZD; Peddada SD; Factor SA; Molho E; Zabetian CP; Knight R; Payami H
Mov Disord; 2017 May; 32(5):739-749. PubMed ID: 28195358
[TBL] [Abstract][Full Text] [Related]
6. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
Sun MF; Shen YQ
Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
[TBL] [Abstract][Full Text] [Related]
7. Deciphering Gut Microbiota Dysbiosis and Corresponding Genetic and Metabolic Dysregulation in Psoriasis Patients Using Metagenomics Sequencing.
Xiao S; Zhang G; Jiang C; Liu X; Wang X; Li Y; Cheng M; Lv H; Xian F; Guo X; Tan Y
Front Cell Infect Microbiol; 2021; 11():605825. PubMed ID: 33869074
[TBL] [Abstract][Full Text] [Related]
8. Altered gut microbiota in patients with idiopathic Parkinson's disease: an age-sex matched case-control study.
Babacan Yildiz G; Kayacan ZC; Karacan I; Sumbul B; Elibol B; Gelisin O; Akgul O
Acta Neurol Belg; 2023 Jun; 123(3):999-1009. PubMed ID: 36719617
[TBL] [Abstract][Full Text] [Related]
9. A Pilot Microbiota Study in Parkinson's Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models.
Vidal-Martinez G; Chin B; Camarillo C; Herrera GV; Yang B; Sarosiek I; Perez RG
J Parkinsons Dis; 2020; 10(1):185-192. PubMed ID: 31561385
[TBL] [Abstract][Full Text] [Related]
10. Oral, Nasal, and Gut Microbiota in Parkinson's Disease.
Li Z; Lu G; Luo E; Wu B; Li Z; Guo J; Xia Z; Zheng C; Su Q; Zeng Y; Chan WY; Su X; Qiu X; Zheng X; Cai Q; Xu Y; Chen Y; Fan Y; Chen W; Yu Z; Chen X; Zheng C; Wang M; Poon WS; Luo X
Neuroscience; 2022 Jan; 480():65-78. PubMed ID: 34695538
[TBL] [Abstract][Full Text] [Related]
11. Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features.
Li W; Wu X; Hu X; Wang T; Liang S; Duan Y; Jin F; Qin B
Sci China Life Sci; 2017 Nov; 60(11):1223-1233. PubMed ID: 28536926
[TBL] [Abstract][Full Text] [Related]
12. Altered gut microbiota in Parkinson's disease patients with motor complications.
Takahashi K; Nishiwaki H; Ito M; Iwaoka K; Takahashi K; Suzuki Y; Taguchi K; Yamahara K; Tsuboi Y; Kashihara K; Hirayama M; Ohno K; Maeda T
Parkinsonism Relat Disord; 2022 Feb; 95():11-17. PubMed ID: 34954497
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
[TBL] [Abstract][Full Text] [Related]
14. The gut microbiome in Parkinson's disease: A culprit or a bystander?
Keshavarzian A; Engen P; Bonvegna S; Cilia R
Prog Brain Res; 2020; 252():357-450. PubMed ID: 32247371
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota in patients with Parkinson's disease in southern China.
Lin A; Zheng W; He Y; Tang W; Wei X; He R; Huang W; Su Y; Huang Y; Zhou H; Xie H
Parkinsonism Relat Disord; 2018 Aug; 53():82-88. PubMed ID: 29776865
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiome and Serum Metabolome Alterations Associated with Isolated Dystonia.
Ma L; Keng J; Cheng M; Pan H; Feng B; Hu Y; Feng T; Yang F
mSphere; 2021 Aug; 6(4):e0028321. PubMed ID: 34346706
[TBL] [Abstract][Full Text] [Related]
17. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.
Heintz-Buschart A; Pandey U; Wicke T; Sixel-Döring F; Janzen A; Sittig-Wiegand E; Trenkwalder C; Oertel WH; Mollenhauer B; Wilmes P
Mov Disord; 2018 Jan; 33(1):88-98. PubMed ID: 28843021
[TBL] [Abstract][Full Text] [Related]
18. Does Gut Microbiota Influence the Course of Parkinson's Disease? A 3-Year Prospective Exploratory Study in de novo Patients.
Cilia R; Piatti M; Cereda E; Bolliri C; Caronni S; Ferri V; Cassani E; Bonvegna S; Ferrarese C; Zecchinelli AL; Barichella M; Pezzoli G
J Parkinsons Dis; 2021; 11(1):159-170. PubMed ID: 33337387
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation.
Kuai XY; Yao XH; Xu LJ; Zhou YQ; Zhang LP; Liu Y; Pei SF; Zhou CL
Microb Cell Fact; 2021 May; 20(1):98. PubMed ID: 33985520
[TBL] [Abstract][Full Text] [Related]
20. Gut Microbiota Composition in Patients with Neurodegenerative Disorders (Parkinson's and Alzheimer's) and Healthy Controls: A Systematic Review.
Heravi FS; Naseri K; Hu H
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
